http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105497003-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2014-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105497003-B |
| titleOfInvention | Application of the epimedium aglucone in preparation prevention or treatment pulmonary fibrosis medicine |
| abstract | The present invention is claimed epimedium aglucone and is used to prepare prevention or treats the purposes of pulmonary fibrosis medicine, belongs to field of medicaments.Epimedium aglucone of the present invention is the traditional Chinese medicine monomer extracted from traditional Chinese medicine Herba Epimedii, and animal experiment is shown, has significant preventive and therapeutic effect for pulmonary fibrosis.The effect of epimedium aglucone pulmonary fibrosis resistant is curative for effect, side effect is low, there is wide medical applications prospect. |
| priorityDate | 2014-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.